126 related articles for article (PubMed ID: 35004862)
1. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
[TBL] [Abstract][Full Text] [Related]
2. MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
Front Mol Biosci; 2021; 8():702206. PubMed ID: 34859046
[TBL] [Abstract][Full Text] [Related]
3. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types.
Wu SY; Lin KC; Lawal B; Wu ATH; Wu CZ
Comput Struct Biotechnol J; 2021; 19():4970-4983. PubMed ID: 34584637
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells.
Li X; Zeng S; Ding Y; Nie Y; Yang M
Front Mol Biosci; 2022; 9():984209. PubMed ID: 36120547
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer.
Gan J; Meng Q; Li Y
Front Mol Biosci; 2021; 8():653454. PubMed ID: 33928124
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma
Cao L; Zhao Y; Liang Z; Yang J; Wang J; Tian S; Wang Q; Wang B; Zhao H; Jiang F; Ma J
Front Mol Biosci; 2022; 9():1076243. PubMed ID: 36452454
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
Thomopoulou K; Papadaki C; Monastirioti A; Koronakis G; Mala A; Kalapanida D; Mavroudis D; Agelaki S
Front Mol Biosci; 2024; 11():1413164. PubMed ID: 38715706
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
Wang Z; Jia L; Yushu Sun ; Li C; Zhang L; Wang X; Chen H
Front Mol Biosci; 2021; 8():727347. PubMed ID: 34527704
[TBL] [Abstract][Full Text] [Related]
9. Erratum: A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms.
Frontiers Production Office
Front Mol Biosci; 2020; 7():596445. PubMed ID: 33282913
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective.
Guo K; Ma S
Front Mol Biosci; 2021; 8():720653. PubMed ID: 34513926
[TBL] [Abstract][Full Text] [Related]
11. MXD3 regulation of DAOY cell proliferation dictated by time course of activation.
Ngo T; Barisone GA; Lam KS; Dίaz E
BMC Cell Biol; 2014 Jul; 15():30. PubMed ID: 25053245
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():1047151. PubMed ID: 36325327
[TBL] [Abstract][Full Text] [Related]
13. Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.
Ngo T; Corrales A; Bourne T; Elmojahid S; Lam KS; Díaz E
Front Mol Biosci; 2019; 6():5. PubMed ID: 30838212
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
Thomas RG; Surendran SP; Jeong YY
Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: The Cellular Functions and Molecular Mechanisms of G-Quadruplex Unwinding Helicases in Humans.
Liu Y; Zhu X; Wang K; Zhang B; Qiu S
Front Mol Biosci; 2021; 8():833430. PubMed ID: 35127827
[TBL] [Abstract][Full Text] [Related]
16. Role of MXD3 in proliferation of DAOY human medulloblastoma cells.
Barisone GA; Ngo T; Tran M; Cortes D; Shahi MH; Nguyen TV; Perez-Lanza D; Matayasuwan W; Díaz E
PLoS One; 2012; 7(7):e38508. PubMed ID: 22808009
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases.
Kong G; Lee H; Tran Q; Kim C; Park J; Kwon SH; Kim SH; Park J
Front Mol Biosci; 2021; 8():639164. PubMed ID: 33842543
[TBL] [Abstract][Full Text] [Related]
18. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.
Duong C; Yoshida S; Chen C; Barisone G; Diaz E; Li Y; Beckett L; Chung J; Antony R; Nolta J; Nitin N; Satake N
Pediatr Res; 2017 Sep; 82(3):527-535. PubMed ID: 28419087
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.
Scala MC; Di Micco S; Lanzillotta D; Musella S; Di Sarno V; Parrino B; Cascioferro SM; Bifulco G; Trapasso F; Campiglia P; Sala M
Front Mol Biosci; 2022; 9():915838. PubMed ID: 35573730
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: KODAMA exploratory analysis in metabolic phenotyping.
Zinga MM; Abdel-Shafy EA; Melak T; Vignoli A; Piazza S; Zerbini LF; Tenori L; Cacciatore S
Front Mol Biosci; 2023; 10():1165720. PubMed ID: 36968275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
